iPSC-derived exosomes as amphotericin B carriers: a promising approach to combat cryptococcal meningitis
BackgroundCryptococcal meningitis (CM) is a significant global health issue, particularly affecting individuals with HIV. Amphotericin B (AmB) serves as the cornerstone treatment for CM; however, its clinical application is restricted due to limited penetration of the blood–brain barrier and associa...
Saved in:
| Main Authors: | Jingyu Zhao, Wei Fang, Yangjie Gao, Jiquan Chen, Guizhen Wang, Julin Gu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-02-01
|
| Series: | Frontiers in Microbiology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2025.1531425/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of fluconazole and amphotericin B in the control of cryptococcal pneumonia in vivo
by: Zhao Yu, et al.
Published: (2025-01-01) -
Small but mighty: targeted antifungal liposomes of a smaller size are superior in treating cryptococcal meningitis
by: Tuyetnhu Pham, et al.
Published: (2024-12-01) -
Profile and acute mortality outcome of patients admitted with cryptococcal meningitis to an urban district hospital in KwaZulu-Natal, South Africa
by: Benjamin O. Adeyemi, et al.
Published: (2015-04-01) -
Fatal cryptococcal meningitis in an immunocompetent patient
by: Minoosh Shabani, et al.
Published: (2025-06-01) -
Induction Treatment for HIV-Associated Cryptococcal Meningitis: Where Have We Been and Where Are We Going?
by: Dominique Milsap, et al.
Published: (2025-04-01)